Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The human brain: localized H-1 MR spectroscopy at 1.0 T.

R Sauter1, W Loeffler, H Bruhn

  • 1Bereich Medizinische Technik, Siemens AG, Erlangen, Federal Republic of Germany.

Radiology
|July 1, 1990
PubMed
Summary

Proton magnetic resonance (MR) spectroscopy at 1.0 Tesla is feasible for in vivo human brain studies. This technique effectively detects characteristic metabolic alterations in astrocytomas compared to normal brain tissue.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The age and sex dynamics of heterosexual HIV transmission in Zambia: an HPTN 071 (PopART) phylogenetic and modelling study.

medRxiv : the preprint server for health sciences·2026
Same author

Bilateral in vivo assessment of mandibular chewing dynamics using multi-slice real-time MRI: the rotation-translation-ratio in normal and displaced TMJ discs.

Clinical oral investigations·2025
Same author

Blood and liver telomere length, mitochondrial DNA copy number, and hepatic gene expression of mitochondrial dynamics in mid-lactation cows supplemented with l-carnitine under systemic inflammation.

Journal of dairy science·2023
Same author

Effects of dietary l-carnitine supplementation on the response to an inflammatory challenge in mid-lactating dairy cows: Hepatic mRNA abundance of genes involved in fatty acid metabolism.

Journal of dairy science·2021
Same author

Comparison of performance and metabolism from late pregnancy to early lactation in dairy cows with elevated v. normal body condition at dry-off.

Animal : an international journal of animal bioscience·2019
Same author

Improved survival of Swedish glioblastoma patients treated according to Stupp.

Acta neurologica Scandinavica·2018

Area of Science:

  • Neuroimaging
  • Biomedical Engineering
  • Medical Physics

Background:

  • Localized proton magnetic resonance (MR) spectroscopy enables in vivo analysis of human brain metabolites.
  • Previous studies utilized higher field strengths (1.5 and 2.0 T) for brain MR spectroscopy.
  • Understanding brain tumor metabolism non-invasively is crucial for diagnosis and management.

Purpose of the Study:

  • To evaluate the feasibility of localized H-1 MR spectroscopy at a lower field strength of 1.0 T for in vivo human brain investigations.
  • To assess the capability of 1.0 T H-1 MR spectroscopy in detecting metabolic changes associated with brain tumors (astrocytomas).

Main Methods:

  • Proton (H-1) MR spectroscopy was performed using the stimulated echo acquisition mode at 1.0 T.
  • Studies included healthy volunteers (frontoparietal area, occipital lobe, cerebellum, pons) and two patients with astrocytomas.

Related Experiment Videos

  • Fast low angle shot MR imaging was used to define regions of interest prior to spectral acquisition.

    • Main Results:

    • H-1 MR spectra from astrocytomas showed characteristic alterations compared to normal brain tissue.
    • Observed changes included reduced N-acetyl-aspartate and creatine resonances, increased choline signals, and a prominent lactate peak.
    • The study demonstrated feasibility at 1.0 T with comparable spectral resolution and signal-to-noise ratio for key metabolites to higher field strengths.

    Conclusions:

    • Localized H-1 MR spectroscopy at 1.0 T is a viable technique for in vivo human brain studies.
    • This lower field strength provides sufficient spectral quality to identify metabolic profiles of brain tumors.
    • The findings support the use of 1.0 T MR spectroscopy as an accessible tool for neuro-oncology research and potentially clinical applications.